Table 4.
Fed serum glucose (mg/dL) of the experimental groups on days 1, 3 and 6 of the study.
| Day | Group | |||
|---|---|---|---|---|
| DEX-LL | DEX-LL (H2O) | DEX-LH | DEX-LH (H2O) | |
| 1 | 104.8 ± 4.07 | 100.2 ± 4.14 | 114.7 ± 4.78 | 100.3 ± 4.95 |
| 3 | 196.5 ± 17.27 b | 175.4 ± 9.49 b | 178.1 ± 15.18 | 177.4 ± 10.16 b |
| 6 | 255.2 ± 23.44 b | 286.1 ± 37.34 a,b | 215.6 ± 22.33 b | 314.8 ± 39.34 a,b |
Values are expressed as mean ± SE. DEXA treated group plus low dose of leucine supplementation via gavage (DEX-LL; n = 10); DEXA treated group plus low dose of leucine supplementation via drinking water (DEX-LL (H2O); n = 10); DEXA treated group plus high dose of leucine supplementation via gavage (DEX-LH; n = 10). DEXA treated group plus high dose of leucine supplementation via drinking water (DEX-LH (H2O); n = 10). a p < 0.05 vs. DEX-LH in the same day of treatment; b p < 0.05 vs. day 1 in the same group.